EUCALIA

EUCALIA EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of EUCALIA (286A.T) as of Nov 3, 2026 is -17.23. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -884.70 — a change of -98.05% (higher).

EV/FCF

-17.23

YoY

-98.05%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of EUCALIA is 2025 -17.23 . EV/FCF (Enterprise Value to Free Cash Flow) of EUCALIA was 2024 -884.70 . It decreases by -98.05% higher compared to the previous year.

The EUCALIA EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2022
25.82 JPY
Jan 1, 2023
-9.55 JPY
Jan 1, 2024
-884.70 JPY
Jan 1, 2025
-17.23 JPY
The EUCALIA EV/FCF history
YEAREV/FCFYoY
-17.23-98.05%
-884.70+9,167.27%
-9.55-136.98%
25.82—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EUCALIA Stock analysis

What does EUCALIA do? EUCALIA Inc generates revenue through three core business segments. The Medical Management Comprehensive Support Business offers management consulting, personnel recruitment, DX support, and fundraising for medical corporations. The Senior Related Business provides nursing care facility operations, admission consultation, and facility introduction services. The Highly Controlled Medical Device Business sells contact lenses and supplies pharmaceutical companies with treatment progress data analysis and sales activity support. Subsidiaries contribute through venture investment, brain checkup services, and real estate transactions. Pharmaceutical companies purchase treatment progress data analysis and sales activity support services. Medical corporations utilize management consulting, recruitment, DX, and fundraising support. Nursing care facility operators and potential residents engage with senior care services. Venture investments and real estate transactions are handled by subsidiaries, supporting the company's broader financial ecosystem. The company's revenue streams are diversified across healthcare support, senior care services, and medical device manufacturing. Medical corporations, pharmaceutical firms, and nursing care facility stakeholders form the primary customer base. Subsidiary activities in venture investment and real estate complement the core business model without direct revenue generation from these segments. EUCALIA is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EUCALIA stock

EV/FCF (Enterprise Value to Free Cash Flow) of EUCALIA is -17.23 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of EUCALIA changed from -884.70 to -17.23, representing a -98.05% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) EUCALIA since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s EUCALIA with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — EUCALIA

All Key Metrics — EUCALIA